nicorandil has been researched along with Acute Disease in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (26.32) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 7 (36.84) | 24.3611 |
| 2020's | 3 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| An, S; Huang, H; Jiang, Y; Wang, H | 1 |
| Li, W; Zhang, G | 1 |
| Li, K; Sun, H; Wang, L; Xu, L; Yang, X; Zhang, Z | 1 |
| Ji, Z; Lu, W; Ma, G; Qu, Y; Zhang, R | 1 |
| Baden, M; Iwasaka, T; Nakamura, S; Shimojo, M; Sugiura, T; Tsuka, Y; Umemura, S | 1 |
| Abdel-Hamid, NM; Abdel-Raheim, SR; El-Moselhy, MA | 1 |
| Kajimoto, K; Shimamura, K | 1 |
| Hagiwara, N; Kajimoto, K; Minami, Y; Nagashima, M; Shiga, T | 1 |
| Ausobsky, JR; Bhasin, N; Davies, JB; Mosley, F | 1 |
| Asanoi, H; Kamijo, T; Katagiri, T; Kato, K; Nakashima, M; Nejima, J; Sakanashi, M; Takano, T; Tanaka, K | 1 |
| Asai, K; Hata, N; Kobayashi, N; Mizuno, K; Shinada, T; Shirakabe, A; Yokoyama, S | 1 |
| Fujishima, S; Haga, Y; Ishihara, S; Ishitsuka, T; Kaseda, S; Koga, T; Nyuta, E; Sadoshima, S | 1 |
| Hirasawa, S; Izumi, T; Masuda, R; Masuda, T; Niwano, H; Niwano, S; Sasaki, S; Sato, K | 1 |
| Abe, N; Fujiwara, T; Hanada, H; Higuma, T; Kameda, K; Matsunaga, T; Okumura, K; Ono, H; Osanai, T; Yokoyama, J | 1 |
| Gomita, Y; Oishi, R; Saeki, K; Yamori, M | 1 |
| Daikoku, S; Goto, Y; Haze, K; Itoh, A; Kobayashi, Y; Miyazaki, S; Nonogi, H; Ohshima, S | 1 |
| Koyama, T; Matsuzaki, T; Nakasone, J; Noguchi, K; Ojiri, Y; Sakanashi, M | 1 |
| Ito, S; Nishikado, A; Sakabe, K; Shinohara, H; Wakatsuki, T | 1 |
| Kamei, K; Kamijo, T; Kamiyama, T; Ohba, Y; Sudo, H; Sugo, I | 1 |
2 review(s) available for nicorandil and Acute Disease
| Article | Year |
|---|---|
Nicorandil prior to primary percutaneous coronary intervention improves clinical outcomes in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.
Topics: Acute Disease; Antihypertensive Agents; Humans; Myocardial Infarction; Nicorandil; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Treatment Outcome | 2019 |
The effect of nicorandil in patients with acute myocardial infarction undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
Topics: Acute Disease; Female; Humans; Male; Myocardial Infarction; Nicorandil; Percutaneous Coronary Intervention; Prognosis; Randomized Controlled Trials as Topic; Vasodilator Agents | 2020 |
7 trial(s) available for nicorandil and Acute Disease
| Article | Year |
|---|---|
Prophylactically injection of Nicorandil to reduce no-reflow phenomenon during PCI in acute STEMI patients: Protocol of a double-blinded, randomized, placebo-controlled trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Injections; Male; Middle Aged; Nicorandil; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; ST Elevation Myocardial Infarction; Treatment Outcome; Vasodilator Agents; Young Adult | 2021 |
Acute efficacy and safety of intravenous administration of nicorandil in patients with acute heart failure syndromes: usefulness of noninvasive echocardiographic hemodynamic evaluation.
Topics: Acute Disease; Aged; Aged, 80 and over; Echocardiography, Doppler; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Nicorandil; Syndrome; Treatment Outcome; Vasodilator Agents | 2009 |
Acute effects of intravenous nicorandil on hemodynamics in patients hospitalized with acute decompensated heart failure.
Topics: Acute Disease; Aged; Female; Heart Failure; Hemodynamics; Hospitalization; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Nicorandil; Pulmonary Wedge Pressure; Vasodilator Agents | 2010 |
Efficacy and safety of nicorandil therapy in patients with acute heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Biomarkers; Blood Pressure; Female; Heart Failure; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Natriuretic Peptide, Brain; Nicorandil; Peptide Fragments; Vasodilator Agents | 2010 |
Effects of intravenous nicorandil on the mid-term prognosis of patients with acute heart failure syndrome.
Topics: Acute Disease; Age Factors; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Disease-Free Survival; Female; Follow-Up Studies; Heart Failure; Humans; Infusions, Intravenous; Male; Nicorandil; Retrospective Studies; Survival Rate; Syndrome | 2012 |
Nicorandil suppresses the increases in plasma level of matrix metalloproteinase activity and attenuates left ventricular remodeling in patients with acute myocardial infarction.
Topics: Acute Disease; Aged; Angiography; Electrophoresis, Polyacrylamide Gel; Female; Gene Expression Regulation; Humans; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Middle Aged; Myocardial Infarction; Nicorandil; Vasodilator Agents; Ventricular Remodeling | 2007 |
Cardioprotective effect of intravenous nicorandil in patients with successful reperfusion for acute myocardial infarction.
Topics: Acute Disease; Anti-Arrhythmia Agents; Humans; Injections, Intravenous; Myocardial Infarction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Niacinamide; Nicorandil; Potassium Channels | 1998 |
10 other study(ies) available for nicorandil and Acute Disease
| Article | Year |
|---|---|
Impact of administration of nicorandil prior to percutaneous coronary intervention in treatment of acute myocardial infarction: A protocol for systematic review and meta-analysis.
Topics: Acute Disease; Combined Modality Therapy; Humans; Meta-Analysis as Topic; Myocardial Infarction; Nicorandil; Observational Studies as Topic; Percutaneous Coronary Intervention; Preoperative Care; Randomized Controlled Trials as Topic; Research Design; Systematic Reviews as Topic; Treatment Outcome; Vasodilator Agents | 2021 |
Preservation of myocardial viability within the risk area by intravenous nicorandil before primary coronary intervention in patients with acute myocardial infarction.
Topics: Acute Disease; Aged; Angioplasty, Balloon, Coronary; Female; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Myocardium; Nicorandil; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2008 |
Gastroprotective effect of nicorandil in indomethacin and alcohol-induced acute ulcers.
Topics: Acute Disease; Animals; Ethanol; Gastric Mucosa; Indomethacin; Male; Nicorandil; Nitric Oxide; Protective Agents; Rats; Rats, Wistar; Stomach Ulcer; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha | 2009 |
Acute efficacy of combined therapy of carperitide and nicorandil for acute decompensated heart failure with left ventricular systolic dysfunction.
Topics: Acute Disease; Atrial Natriuretic Factor; Drug Therapy, Combination; Female; Heart Failure; Humans; Middle Aged; Nicorandil; Treatment Outcome; Ventricular Dysfunction, Left | 2011 |
Life-threatening haemorrhage secondary to nicorandil-induced severe peri-anal ulceration.
Topics: Acute Disease; Aged; Anus Diseases; Fissure in Ano; Hemorrhage; Humans; Male; Nicorandil; Vasodilator Agents | 2010 |
Cardioprotective effects of sarcolemmal and mitochondrial K-ATP channel openers in an experimental model of autoimmune myocarditis. Role of the reduction in calcium overload during acute heart failure.
Topics: Action Potentials; Acute Disease; Animals; Anti-Arrhythmia Agents; Autoimmune Diseases; Calcium; Echocardiography; Electrophysiology; Heart Failure; KATP Channels; Mexiletine; Mitochondria, Heart; Myocarditis; Nicorandil; Rats; Sarcolemma; Ventricular Function, Left | 2012 |
Effect of acute and chronic immobilization stress on plasma levels of nicorandil administered orally to rats.
Topics: Acute Disease; Administration, Oral; Animals; Chronic Disease; Intestinal Absorption; Male; Niacinamide; Nicorandil; Rats; Rats, Wistar; Stress, Psychological | 1994 |
Beneficial hemodynamic effects of nicorandil in a canine model of acute congestive heart failure: comparison with nitroglycerin and cromakalim.
Topics: Acute Disease; Animals; Blood Pressure; Coronary Circulation; Cromakalim; Disease Models, Animal; Dogs; Female; Heart; Heart Failure; Heart Rate; Male; Myocardial Contraction; Myocardium; Niacinamide; Nicorandil; Nitroglycerin; Saponins; Vasodilator Agents | 1998 |
The effects of nicorandil on electrophysiological changes in acute myocardial ischemia and reperfusion.
Topics: Acute Disease; Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Dogs; Drug Evaluation, Preclinical; Electrophysiology; Myocardial Ischemia; Myocardial Reperfusion Injury; Niacinamide; Nicorandil; Potassium Channels; Ventricular Fibrillation | 1998 |
Hemodynamic and hormonal responses to nicorandil in a canine model of acute ischemic heart failure: a comparison with cromakalim and nitroglycerin.
Topics: Acute Disease; Animals; Atrial Natriuretic Factor; Cardiac Output, Low; Cromakalim; Dogs; Embolization, Therapeutic; Female; Hemodynamics; Hormones; Male; Microspheres; Myocardial Ischemia; Natriuretic Peptide, Brain; Nicorandil; Nitroglycerin; Potassium Channels; Renin; Vasodilator Agents | 1999 |